CJC1295 with DAC — Growth Hormone Research Peptide

CJC1295 with DAC (Drug Affinity Complex) is a modified growth hormone releasing hormone analogue designed for extended activity in laboratory research environments. The compound is widely researched for its role in growth hormone pathway modulation and endocrine signaling investigations.

The addition of DAC technology is studied for prolonged peptide stability and sustained receptor interaction compared to standard GHRH analogues.

Researchers investigate CJC1295 with DAC in studies involving growth hormone secretion pathways, IGF-1 signaling, recovery mechanisms, and metabolic research models.

AURION CJC1295 with DAC is manufactured as a premium laboratory-grade lyophilized peptide intended strictly for advanced research applications.

Research Applications

• Growth hormone pathway studies
• IGF-1 signaling investigations
• Endocrine system research
• Recovery pathway analysis
• Metabolic signaling studies
• Hormonal modulation research

Product Specifications

• Purity: ≥99%
• Lyophilized peptide powder
• Laboratory tested
• Research grade quality
• Refrigerated storage recommended
• Research use only

For laboratory research only. Not for human or animal consumption.